Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response

Circulation

Volumn 99, Issue 18, 1999, Pages 2445-2451

  Hennuyer, Nathalie ^e   Poulain, Philippe ^e   Madsen, Lise ^a   Berge, Rolf K ^a   Houdebine, Louis Marie ^c   Branellec, Didier ^b   Fruchart, Jean Charles ^e   Fiévet, Catherine ^e   Duverger, Nicolas ^b   Staels, Bart ^d  

^a UNIVERSITY OF BERGEN   (Norway)

^b SANOFI   (France)

^c CEMAGREF   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e NONE

Author keywords

Apolipoproteins; Drugs; Genes; Lipids; Receptors

Indexed keywords

APOLIPOPROTEIN A1; FIBRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GENETIC REGULATION; LIPOPROTEIN METABOLISM; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033545824     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.18.2445     Document Type: Article

References (31)

1. Staels B, Auwerx J. Role of PPAR in the pharmacological regulation of lipoprotein metabolism by fibrates and thiazolidinediones. Curr Pharmaceutical Des. 1997;3:1-14.
2. Schoonjans K, Peinado-Onsurbe J, Lefebvre A-M, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 1996;15:5336-5348.
3. Staels B, Vu-Dac N, Kosykh VA, Saladin R, Fruchart JC, Dallongeville J, Auwerx J. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. J Clin Invest. 1995;95:705-712.
4. Vu-Dac N, Schoonjans K, Laine B, Fruchart JC, Auwerx J, Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem. 1994;269: 31012-31018.
5. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart J-C, Staels B, Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest. 1995;96:741-750.
6. Berthou L, Duverger N, Emmanuel F, Langouët S, Auwerx J, Guillouzo A, Fruchart J-C, Rubin E, Denèfle P, Staels B, Branellec D. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apo A-I transgenic mice. J Clin Invest. 1996;97:2408-2416.
7. Berthou L, Saladin R, Yaqoob P, Branellec D, Calder P, Fruchart JC, Denefle P, Auwerx J, Staels B. Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II, and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids. Eur J Biochem. 1995;232:179-187.
8. Staels B, Van Tol A, Andreu T, Auwerx J. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler Thromb. 1992;12:286-294.
9. Hertz R, Bishara-Shieban J, Bar-Tana J. Mode of action of peroxisome proliferators as hypolipidemic drugs: suppression of apolipoprotein C-III. J Biol Chem. 1995;270:13470-13475.
10. Lock EA, Mitchell AM, Elcombe CR. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol. 1989;29:145-163.
11. Reddy JK, Lalwani ND. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol. 1983;12:1-58.
12. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol. 1995;15:3012-3022.
13. Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi T, Hashimoto T, Lalwani ND, Rao MS. Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci U S A. 1986;83:1747-1751.
14. Dirven HA, van den Broek PH, Peeters MC, Peters JG, Mennes WC, Blaauboer BJ, Noordhoek J, Jongeneelen FJ. Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate in primary hepatocyte cultures derived from rat, guinea pig, rabbit and monkey: relationship between interspecies differences in biotransformation and peroxisome proliferating potencies. Biochem Pharmacol. 1993;45:2425-2434.
15. Duverger N, Viglietta C, Berthou L, Emmanuel F, Tailleux A, Parmentier-Nihoul L, Laine B, Fievet C, Castro G, Fruchart JC, Houdebine LM, Denèfle P. Transgenic rabbits expressing human apolipoprotein A-I in the liver. Arterioscler Thromb Vasc Biol. 1996;16: 1424-1429.
16. Small GM, Burdett K, Connock MJ. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J. 1985;227:205-210.
17. Pan TC, Hao Q-L, Yamin T-T, Dai P-H, Chen B-S, Chen S-L, Kroon PA, Chao Y-S. Rabbit apolipoprotein A-I mRNA and gene: evidence that rabbit apolipoprotein A-I is synthesized in the intestine but not in the liver. Eur J Biochem. 1987;170:99-104.
18. Tugwood JD, Isseman I, Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 1992;11:433-439.
19. Gordon T, Castelli WP, Hjörtland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
20. Östlund Farrants A-K, Nilsson A, Troen G, Blomhoff R, Pedersen JI. The effect of retinoids and clofibric acid on the peroxisomal oxidation of palmitic acid and of 3α, 7α, 12α-trihydroxy-5β-cholestanoic acid in rat and rabbit hepatocytes. Biochim Biophys Acta. 1993;1168:100-107.
21. Rea TJ, DeMattos RB, Pape ME. Hepatic expression of genes regulating lipid metabolism in rabbits. J Lipid Res. 1993;34:1901-1910.
22. Staels B, van Tol A, Verhoeven G, Auwerx J. Apolipoprotein A-IV messenger ribonucleic acid abundance is regulated in a tissue-specific manner. Endocrinology. 1990;126:2153-2163.
23. Vu-Dac N, Chopin-Delannoy S, Gervois P, Bonnelye E, Martin G, Fruchart J-C, Laudet V, Staels B. The nuclear receptors PPARα and Reverbα mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem. 1998;273:25713-25718.
24. Ha YC, Barter PJ. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol. 1982;71B:265-269.
25. Bardot O, Clemencet M-C, Cherkaoui Malki M, Latruffe N. Delayed effects of ciprofibrate on rat liver peroxisomal properties and protooncogene expression. Biochem Pharmacol. 1995;50:1001-1006.
26. Hanefeld M, Kemmer C, Kadner E. Relationship between morphological changes and lipid lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis. 1983;46:239-246.
27. Blümcke S, Schwartzkopff W, Lobeck H, Edmondson NA, Prentice DE, Blane GF. Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients. Atherosclerosis. 1983;46:105-116.
28. De la Iglesia FA, Lewis JE, Buchanan RA, Marcus EL, McMahon G. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis. 1982;43:19-23.
29. Blaauboer BJ, van Holsteijn CW, Bleumink R, Mennes WC, van Pelt FN, Yap SH, van Pelt JF, van Iersel AA, Timmerman A, Schmid BP. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem Pharmacol. 1990;40:521-528.
30. Passilly P, Jannin B, Hassell SJ, Latruffe N. Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry. Exp Cell Res. 1996; 223:436-442.
31. Hertz R, Arnon J, Hoter A, Shouval D, Bar-Tana J. Clofibrate does not induce peroxisome proliferation in human hepatome cell lines PLC/PRF/S and SK-HEP-1. Cancer Lett. 1987;34:263-272.